Amylin Pharmaceuticals (AMLN) Sees Late Day Pressure
Tweet
Share
E-mailGet Alerts AMLN Hot Sheet
Join SI Premium – FREE
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) sees downside action late in the session. Share are down 3%.
In March the company rejected a $22 share bid from Brisol-Myers (NYSE: BMY), although others are said to come with higher bids.
Today's action suggest some may be dropping out of the bidding, although we haven't seen anything official.
In March the company rejected a $22 share bid from Brisol-Myers (NYSE: BMY), although others are said to come with higher bids.
Today's action suggest some may be dropping out of the bidding, although we haven't seen anything official.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA (NVDA) in talks to invest in data-center company Cloverleaf Infrastructure - WSJ
- SpaceX attempted to acquire AI coding startup Cognition - Bloomberg
- Two Binance Employees Detained In The U.A.E. Amid Police Inquiries - NYT
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
